Introduction
============

Huntington's Disease (HD) is an inherited neurodegenerative disorder that is characterized by progressive motor, cognitive, and behavioral decline. It is inherited in an autosomal dominant pattern, with the number of CAG repeats in the HTT gene being the strongest determinant of age of onset \[[@B1]\]. Average age of onset is about 40 years old, with a range from childhood to the eighth decade \[[@B2][@B3]\]. It has been suggested that older onset patients are more likely to present with motor manifestations, and younger patients with psychiatric/behavioral manifestations \[[@B4]\]. However, phenotypic differences by age of onset have not been well-characterized in the HD literature, likely due to sample size limitations of most studies. Furthermore, whether phenotypic differences persist or vary by disease stage has not been previously described. There remains a lack of clarity on the relationship between age of onset and HD progression. In a 1995 study, Feigin et al. reported no significant connection between rate of functional decline and age of onset \[[@B5]\]. A more recent publication described a significant association between younger age of onset and faster decline in UHDRS motor score and Independence Scale, but did not find an association with Total Functional Capacity (TFC) \[[@B6]\]. Using the large database of HD patients from Enroll-HD, we characterized HD phenotype and functional decline by age group across the spectrum of disease severity. Knowledge of the phenotypic profile and rate of progression by age of onset will inform standard of care recommendations and aim to improve the quality of care for HD patients.

Methods
=======

This study is a cross-sectional analysis of prospectively collected data from manifest HD subjects in the Enroll-HD database. Enroll-HD began in 2012 as part of an observational, multi-national, multi-center study and contains longitudinal clinical information on over 15,000 participants as of December 2018. This dataset includes 3,802 participants from the European REGISTRY study that preceded Enroll-HD \[[@B7]\]. Study participants are recruited from specialty clinics and enrolled from 125 sites located in 13 countries across four continents. Each study site is evaluated by an IRB or equivalent ethics committee. Enroll-HD collects deidentified data from participants at annual study visits and utilizes a risk-based monitoring strategy to maintain data quality \[[@B8]\]. The data for this study was from the dataset cutoff made available in December 2018.

Participants with manifest/motor-manifest HD at enrollment were included. Participants younger than 20 years of age at symptom onset were excluded to remove those with juvenile-onset Huntington's disease, which differs significantly in phenotype from adult-onset HD and has already been well-characterized in the literature as a distinct clinical presentation \[[@B9][@B10]\]. Age groups were defined as follows: young onset (20--29 years), typical onset (30--59 years), and late onset (60+ years). Typical and late onset age group cutoffs have been used and validated by previous studies \[[@B11][@B12][@B13][@B14][@B15]\]. Age of onset was determined by Enroll-HD rater's estimate of symptom onset. Subjects in each group were categorized into TFC total score bins, from Stage I (least severe) to Stage V (most severe). TFC Total Score 11--13 is characterized as Stage I, 7--10 is Stage II, 3--6 is Stage III, 1--2 is Stage IV, and 0 is Stage V. For the purposes of analysis, TFC scores were grouped into 3 previously validated categories: early (stage I and II), moderate (stage III), and advanced (stages IV and V) \[[@B16][@B17]\]. These TFC score stages are utilized in clinical practice and in contemporary research studies \[[@B13][@B18][@B19]\].

Demographic data and motor, cognitive, and behavioral measures were analyzed. Motor variables included the Unified Huntington's Disease Rating Scale (UHDRS) motor score and Timed "Up and Go" test. Cognitive variables included Symbol Digit Modality Test, Verbal Fluency Test (Category), Verbal Fluency Test (Letter), Stroop Color Naming Test, Stroop Word Reading Test, and Stroop Interference Test. For the above measures, percentage correct was calculated by dividing total correct answers by total answers. Percentage correct was used for analyses. Mini Mental State Examination (MMSE) score was also included as a measure of cognitive function.

Behavioral measures included quantification of drug and alcohol abuse; Hospital Anxiety and Depression Scale -- Snaith Irritability Scale (HADS-SIS) anxiety, depression, irritability, outward irritability, and inward irritability subscores, total number of suicide attempts (from Columbia-Suicide Rating Scale baseline and follow-up); and Problem Behaviours Assessment -- Short (PBA-s) Depression, Irritability aggression, Psychosis, Apathy, Executive function, Depressed mood frequency, Suicidal ideation frequency, Anxiety frequency, Irritability frequency, Angry or aggressive behavior frequency, Lack of initiative (apathy) frequency, Perseverative thinking or behavior frequency, Obsessive-Compulsive Behaviors frequency, Delusions frequency, Hallucinations frequency, Disoriented Behavior frequency. For all PBA-s frequency variables, responses were converted to and analyzed as binary variables: not present (coded as *0-absent*) vs. present (includes *1-slight, questionable, 2-mild, 3-moderate*, and *4-severe*).

Data Analysis
-------------

Descriptive statistics were calculated for all variables of interest. Categorical variables were summarized with counts and percentages, and continuous variables with means and standard deviations or median and interquartile range, as appropriate. The drug and alcohol abuse variables were binary variables (yes/no). TFC score at baseline was utilized to sort participants into early, moderate, and advanced disease stage. Chi-square test, Fisher's exact test, and Kruskal-Wallis test, as appropriate, were used to determine p-values. P-values less than 0.05 were considered significant for overall comparison. As we aimed to identify any factors potentially associated with age of onset, we did not consider p-value correction on potential factors. However, Bonferroni p-value correction was used to do pairwise comparison for post-hoc analysis. Bonferroni corrected p-values less than 0.01667 were considered significant when we compared 3 combinations of age of onset groups. In this context, we viewed control over type II error more important than control over type I error. In addition, the analyses were deemed exploratory overall and the primary focus was not to generate a precise, predictive model.

Sensitivity analysis was conducted to determine the average change in TFC score between age of onset groups, excluding participants whose first visit was outside 6 months to 1.5 years after baseline visit, participants whose second visit was outside 1.5 year to 2.5 years after baseline, and participants whose third visit was outside 2.5 years to 3.5 years after baseline. Follow-up visits for Enroll-HD are to be conducted annually, and these exclusions remove variation from that timeline. Additionally, only participants who had TFC scores for their baseline, first visit, second visit, and third visit were included. ANOVA was used to compare mean TFC score change from baseline between age of onset groups. The same parameters were used for a sensitivity analysis of average change in UHDRS Functional Assessment Independence Scale.

Results
=======

7,311 manifest HD subjects were included in the analysis of which 612 were young onset, 5,776 typical onset, and 923 late onset. There were 15,301 total participants in the Enroll-HD database, of which 8,043 had manifest HD. 176 participants were excluded due to age \<20 and 556 were excluded due to missing age of onset value. Participants were 51.5% female, 94.3% white/Caucasian, and average CAG repeats in the HTT gene was 43.8. The average age of clinical HD diagnosis in our adult study population was 49.2 years (Table [1](#T1){ref-type="table"}).

###### 

Demographic Characteristics.

  ------------------------------------------------------ --------------------- ------------- ------- ------- ------- ------- ------- -------
                                                         Age of Onset Groups   ALL                                                   

                                                                                                                                     

  Young onset\                                           Typical onset\        Late onset\                                           
  (20--29 years)                                         (30--59 years)        (60+ years)                                           

                                                                                                                                     

  N                                                      \%                    N             \%      N       \%      N       \%      

                                                                                                                                     

  TFC stage                                                                                                                          

        Stage I (11--13)                                 191                   31.31         1864    32.30   278     30.18   2333    31.95

        Stage II (7--10)                                 198                   32.46         2025    35.09   347     37.68   2570    35.20

        Stage III (3--6)                                 139                   22.79         1265    21.92   215     23.34   1619    22.17

        Stage IV (1--2)                                  54                    8.85          445     7.71    67      7.27    566     7.75

        Stage V (0)                                      28                    4.59          172     2.98    14      1.52    214     2.93

  TFC stage                                                                                                                          

        Early (Stage I & II)                             389                   63.77         3889    67.39   625     67.86   4903    67.15

        Moderate (Stage III)                             139                   22.79         1265    21.92   215     23.34   1619    22.17

        Advanced (Stage IV & V)                          82                    13.44         617     10.69   81      8.79    780     10.68

  Sex                                                                                                                                

        Female                                           319                   52.12         2998    51.90   445     48.21   3762    51.46

        Male                                             293                   47.88         2778    48.10   478     51.79   3549    48.54

  Race                                                                                                                               

        Other                                            41                    6.70          335     5.80    39      4.23    415     5.68

        White/Caucasian                                  571                   93.30         5441    94.20   884     95.77   6896    94.32

  Has Mother Affected                                    279                   46.66         2660    47.75   365     45.23   3304    47.36

  Has Father Affected                                    308                   51.85         2602    47.12   278     34.71   3188    46.09

  Has Family History                                     526                   85.95         4866    84.25   788     85.37   6180    84.53

  Marital Status                                                                                                                     

        Married/Partnership                              199                   32.52         3782    65.56   691     74.95   4672    63.97

        Single/Divorced/Widowed/Legally Separated        413                   67.48         1987    34.44   231     25.05   2631    36.03

  ISCED Education Level                                                                                                              

        Less than or equal to 12th grade                 374                   61.41         3217    55.96   541     58.87   4132    56.78

        Higher than 12th grade                           235                   38.59         2532    44.04   378     41.13   3145    43.22

  Employment Status                                                                                                                  

        Employed                                         129                   21.11         1302    22.59   79      8.60    1510    20.70

        Not Employed                                     482                   78.89         4461    77.41   840     91.40   5783    79.30

  Rater's Judgement of Initial Major Symptom                                                                                         

        Motor                                            269                   44.39         2966    51.51   631     68.36   3866    53.05

        Cognitive                                        46                    7.59          489     8.49    42      4.55    577     7.92

        Psychiatric                                      165                   27.23         1197    20.79   104     11.27   1466    20.12

        Oculomotor/Other/Mixed                           126                   20.79         1106    19.21   146     15.82   1378    18.91

                                                         Mean                  SD            Mean    SD      Mean    SD      Mean    SD

        BMI                                              24.32                 5.43          25.03   5.03    25.02   4.31    24.97   4.99

        Age of clinical HD diagnosis                     29.83                 6.25          48.27   8.72    67.92   5.57    49.22   11.99

        Larger research CAG allele determined from DNA   49.81                 4.67          43.59   2.49    40.75   1.19    43.75   3.34
  ------------------------------------------------------ --------------------- ------------- ------- ------- ------- ------- ------- -------

Missing values were encountered in 9 (0.12%) for TFC score, 335 (4.58%) for mother affected, 394 (5.39%) for father affected, 8 (0.11%) for marital status, 34 (0.47%) for education level, 18 (0.25%) for employment status, 24 (0.33%) for rater's judgement of initial major symptom, 235 (3.21%) in BMI, and 140 (1.91%) in age of clinical HD diagnosis.

Motor Variables
---------------

At early (TFC I-II) and advanced (TFC IV-V) stages of disease, motor function varied based on age of onset. At early stages of disease, the late age of onset group had worse motor function compared to the young and typical age of onset groups, with significantly worse UHDRS Motor scores in late onset (median \[Q1--Q3\] = 30.00 \[20.00--39.00\]) compared to young onset (25.00 \[15.00--38.00\], p-value = 0.00007) and typical onset participants (27.00 \[18.00--38.00\], p = 0.0003).

At advanced stages of disease, all the age groups had significantly different motor function. The young onset group had worse UHDRS motor scores (83.00 \[70.00--91.50\]) compared to the typical onset (75.00 \[63.00--87.00\], p = 0.003) and late onset participants (65.00 \[53.00--77.00\], p \< 0.001). The typical onset group also had significantly worse motor scores compared to the late onset group (p \< 0.001) (Table [2](#T2){ref-type="table"}).

###### 

Motor and Cognitive Variables by Age of Onset Groups and TFC Stages.

  ---------------------------------------------- -------------------------- ------------------------- -------------------------- ------------------------- -------------------------- ------------------------- ------------------------- ---------------
                                                 TFC Score Category         Young                     Typical                                              Late                       P-value                                             
                                                                                                                                                                                                                                          
  N                                              Median (Q1--Q3) or N (%)   N                         Median (Q1--Q3) or N (%)   N                         Median (Q1--Q3) or N (%)                                                       
                                                                                                                                                                                                                                          
  **Motor Symptoms**                                                                                                                                                                                                                      
  UHDRS Motor score (TMS)                        Early                      387                       25.00 (15.00, 38.00)       3871                      27.00 (18.00, 38.00)       619                       30.00 (20.00, 39.00)      **\* \<0.01**
  Moderate                                       139                        56.00 (39.00, 67.00)      1248                       51.00 (38.50, 63.00)      214                        51.00 (39.00, 60.00)      0.13                      
  Advanced                                       80                         83.00 (70.00, 91.50)      609                        75.00 (63.00, 87.00)      79                         65.00 (53.00, 77.00)      **\* \<0.01**             
  Timed "Up and Go" Total time                   Early                      190                       8.75 (7.00, 11.00)         1661                      9.00 (7.40, 11.00)         252                       10.00 (8.80, 13.00)       **\* \<0.01**
  Moderate                                       45                         11.00 (9.00, 15.00)       462                        12.00 (9.50, 16.00)       63                         14.00 (11.00, 20.00)      **\* 0.02**               
  Advanced                                       10                         14.00 (12.00, 21.00)      72                         15.50 (10.00, 23.00)      12                         17.00 (15.00, 26.50)      0.47                      
  **Cognitive Symptoms**                                                                                                                                                                                                                  
  Symbol Digit Modality Test Total correct %     Early                      384                       100.00 (93.75, 100.00)     3819                      100.00 (95.00, 100.00)     609                       100.00 (93.33, 100.00)    **\* 0.02**
  Moderate                                       118                        100.00 (86.67, 100.00)    1104                       96.23 (86.36, 100.00)     187                        95.00 (75.00, 100.00)     0.13                      
  Advanced                                       52                         0.00 (0.00, 87.78)        398                        0.00 (0.00, 94.74)        45                         50.00 (0.00, 100.00)      0.16                      
  Verbal Fluency Test Total correct % Category   Early                      384                       100.00 (93.22, 100.00)     3847                      100.00 (90.91, 100.00)     622                       100.00 (90.91, 100.00)    **\* 0.01**
  Moderate                                       134                        100.00 (87.50, 100.00)    1227                       100.00 (85.71, 100.00)    210                        100.00 (83.33, 100.00)    0.41                      
  Advanced                                       65                         85.71 (0.00, 100.00)      491                        85.71 (40.00, 100.00)     67                         100.00 (75.00, 100.00)    **\* 0.03**               
  Verbal Fluency Test Total correct % Letter     Early                      300                       95.45 (90.12, 100.00)      3037                      95.00 (88.89, 100.00)      456                       94.12 (87.50, 100.00)     0.18
  Moderate                                       92                         94.28 (85.96, 100.00)     854                        92.98 (82.61, 100.00)     155                        90.00 (76.00, 100.00)     **\* \<0.01**             
  Advanced                                       41                         80.95 (0.00, 100.00)      277                        76.47 (50.00, 100.00)     41                         85.71 (61.54, 100.00)     0.44                      
  Stroop Color Naming Test Total correct %       Early                      381                       100.00 (100.00, 100.00)    3833                      100.00 (100.00, 100.00)    614                       100.00 (100.00, 100.00)   0.84
  Moderate                                       133                        100.00 (98.63, 100.00)    1206                       100.00 (98.08, 100.00)    202                        100.00 (97.50, 100.00)    0.78                      
  Advanced                                       64                         98.49 (0.00, 100.00)      468                        97.26 (0.00, 100.00)      60                         98.53 (64.38, 100.00)     0.82                      
  Stroop Word Reading test Total correct %       Early                      381                       100.00 (100.00, 100.00)    3831                      100.00 (100.00, 100.00)    614                       100.00 (100.00, 100.00)   0.18
  Moderate                                       129                        100.00 (100.00, 100.00)   1187                       100.00 (100.00, 100.00)   200                        100.00 (100.00, 100.00)   0.65                      
  Advanced                                       63                         96.67 (0.00, 100.00)      457                        100.00 (0.00, 100.00)     60                         100.00 (0.00, 100.00)     0.19                      
  Stroop Interference Test Total correct %       Early                      356                       100.00 (96.08, 100.00)     3511                      100.00 (96.15, 100.00)     548                       100.00 (95.00, 100.00)    0.24
  Moderate                                       106                        100.00 (88.89, 100.00)    956                        100.00 (87.50, 100.00)    155                        94.74 (76.92, 100.00)     **\* 0.02**               
  Advanced                                       38                         95.00 (36.84, 100.00)     281                        88.24 (16.67, 100.00)     33                         84.62 (30.00, 100.00)     0.53                      
  Mini Mental State Examination (MMSE) score     Early                      270                       26.00 (24.00, 29.00)       2562                      27.00 (25.00, 29.00)       393                       27.00 (25.00, 28.00)      0.13
  Moderate                                       80                         24.00 (20.00, 26.50)      725                        23.00 (20.00, 26.00)      128                        23.00 (19.00, 25.00)      0.08                      
  Advanced                                       34                         17.00 (11.00, 22.00)      252                        17.00 (13.00, 21.00)      37                         18.00 (15.00, 22.00)      0.68                      
  ---------------------------------------------- -------------------------- ------------------------- -------------------------- ------------------------- -------------------------- ------------------------- ------------------------- ---------------

\* Significant at level p \< 0.05.

Cognitive Variables
-------------------

The cognitive variables analyzed yielded no clinically significant trends when compared between groups. At early stages of HD, some intergroup differences were seen for Symbol Digit Modality Test (p = 0.02) and Verbal Fluency Test Category (p = 0.01). For instance, the young age of onset group scored slightly better (median \[Q1--Q3\] = 100.00 \[93.22--100.00\]) compared to typical (100.00 \[90.91--100.00\], p = 0.003) and late onset group (100.00 \[90.91--100.00\], p = 0.013) on the Verbal Fluency Test Category. At moderate stages of disease, late onset participants had significantly worse scores compared to typical onset participants compared on the Verbal Fluency Test Letter (90.00 \[76.00--100.00\] vs. 92.98 \[82.61--100.00\], p = 0.003) and Stroop Interference Test (94.74 \[76.92--100.00\] vs. 100.00 \[87.50, 100.00\], p = 0.011) (Table [2](#T2){ref-type="table"}).

Behavioral Variables
--------------------

At early stages of disease, the young onset group tended to have significantly worse behavioral symptoms, including drug and alcohol abuse, anxiety, depression, irritability, aggression, apathy, lack of initiative, obsessive-compulsive behaviors, and delusions when compared to the late onset group (Table [3](#T3){ref-type="table"}). At moderate stages of disease, the late onset group scored significantly worse on HADS-SIS depression and HADS-SIS inward irritability when compared to the young onset group. Young onset participants were more likely to abuse drugs compared to both the typical and late onset groups at early, moderate, and advanced stages of disease (all p \< 0.01) (Appendix A). At advanced stages of disease, young onset participants were more likely to have delusions (29.27% vs. 16.02%, p \< 0.009) and hallucinations (20.73% vs. 7.41%, p = 0.015) when compared to the late onset group (Table [3](#T3){ref-type="table"}).

###### 

Behavioral Variables by Age of Onset Groups and TFC Stages.

  ---------------------------------------------------------------------------- -------------------------- -------------------- -------------------------- -------------------- -------------------------- -------------------- ------------------- ---------------
                                                                               TFC Score Category         Young                Typical                    Late                 P-value                                                             

                                                                                                                                                                                                                                                   

  N                                                                            Median (Q1--Q3) or N (%)   N                    Median (Q1--Q3) or N (%)   N                    Median (Q1--Q3) or N (%)                                            

                                                                                                                                                                                                                                                   

  **Behavioral Symptoms**                                                                                                                                                                                                                          

  Has the participant ever abused drugs?\                                      Early                      389                  77 (19.79)                 3883                 385 (9.92)                 622                  23 (3.70)           **\* \<0.01**
  Yes                                                                                                                                                                                                                                              

  Moderate                                                                     139                        27 (19.42)           1262                       84 (6.66)            214                        4 (1.87)             **\* \<0.01**       

  Advanced                                                                     80                         10 (12.50)           613                        23 (3.75)            81                         0 (0.00)             **\* \<0.01**       

  Has the participant had alcohol problems in the past?\                       Early                      389                  50 (12.85)                 3881                 358 (9.22)                 622                  28 (4.50)           **\* \<0.01**
  Yes                                                                                                                                                                                                                                              

  Moderate                                                                     139                        17 (12.23)           1261                       146 (11.58)          214                        15 (7.01)            0.13                

  Advanced                                                                     81                         8 (9.88)             612                        64 (10.46)           81                         5 (6.17)             0.55                

  HADS-SIS anxiety subscore                                                    Early                      264                  6.00 (3.50, 9.00)          2417                 6.00 (3.00, 9.00)          365                  4.00 (2.00, 7.00)   **\* \<0.01**

  Moderate                                                                     62                         4.00 (2.00, 8.00)    604                        5.00 (3.00, 9.00)    100                        5.00 (3.00, 8.00)    0.28                

  Advanced                                                                     24                         4.00 (2.50, 8.50)    172                        5.00 (3.00, 9.00)    25                         4.00 (2.00, 6.00)    0.40                

  HADS-SIS depression subscore                                                 Early                      264                  5.00 (3.00, 8.00)          2416                 5.00 (3.00, 8.00)          365                  4.00 (2.00, 7.00)   **\* \<0.01**

  Moderate                                                                     62                         5.00 (3.00, 8.00)    602                        7.00 (4.00, 10.00)   99                         8.00 (4.00, 11.00)   **\* \<0.01**       

  Advanced                                                                     24                         7.00 (3.00, 11.00)   176                        8.00 (5.00, 12.00)   25                         7.00 (6.00, 9.00)    0.39                

  HADS-SIS irritability subscore                                               Early                      263                  6.00 (3.00, 10.00)         2413                 6.00 (2.00, 9.00)          365                  5.00 (2.00, 7.00)   **\* \<0.01**

  Moderate                                                                     62                         5.00 (2.00, 8.00)    601                        5.00 (2.00, 9.00)    100                        5.00 (3.00, 8.00)    0.52                

  Advanced                                                                     25                         4.00 (2.00, 8.00)    174                        5.00 (2.00, 8.00)    25                         4.00 (2.00, 7.00)    0.88                

  HADS-SIS outward irritability subscore                                       Early                      263                  4.00 (2.00, 7.00)          2426                 3.00 (1.00, 6.00)          368                  3.00 (1.00, 5.00)   **\* \<0.01**

  Moderate                                                                     62                         3.00 (1.00, 6.00)    604                        3.00 (1.00, 6.00)    101                        3.00 (1.00, 5.00)    0.23                

  Advanced                                                                     25                         3.00 (1.00, 5.00)    175                        3.00 (1.00, 6.00)    25                         2.00 (1.00, 5.00)    0.65                

  HADS-SIS inward irritability subscore                                        Early                      264                  2.00 (0.00, 4.00)          2421                 2.00 (0.00, 4.00)          365                  2.00 (0.00, 3.00)   **\* \<0.01**

  Moderate                                                                     62                         1.00 (0.00, 3.00)    603                        2.00 (0.00, 4.00)    100                        2.50 (1.00, 4.00)    **\* 0.01**         

  Advanced                                                                     25                         1.00 (0.00, 3.00)    174                        1.00 (0.00, 3.00)    25                         1.00 (0.00, 3.00)    0.86                

  Total \# of suicide attempts (C-SSRS BL and FUP)                             Early                      27                   1.00 (1.00, 2.00)          142                  1.00 (1.00, 2.00)          13                   1.00 (1.00, 1.00)   0.55

  Moderate                                                                     19                         1.00 (1.00, 2.00)    75                         1.00 (1.00, 2.00)    7                          1.00 (1.00, 2.00)    0.99                

  Advanced                                                                     5                          2.00 (1.00, 2.00)    32                         1.00 (1.00, 2.50)    3                          1.00 (1.00, 3.00)    0.75                

  PBA-s Depression                                                             Early                      388                  4.00 (0.00, 9.50)          3883                 4.00 (0.00, 8.00)          624                  2.00 (0.00, 6.00)   **\* \<0.01**

  Moderate                                                                     138                        2.50 (0.00, 7.00)    1257                       3.00 (0.00, 8.00)    215                        4.00 (0.00, 8.00)    0.50                

  Advanced                                                                     71                         2.00 (0.00, 8.00)    545                        2.00 (0.00, 8.00)    78                         2.50 (0.00, 8.00)    0.88                

  PBA-s Irritability aggression                                                Early                      386                  2.00 (0.00, 6.00)          3885                 1.00 (0.00, 4.00)          624                  0.50 (0.00, 4.00)   **\* \<0.01**

  Moderate                                                                     138                        1.00 (0.00, 6.00)    1261                       1.00 (0.00, 6.00)    215                        1.00 (0.00, 4.00)    0.13                

  Advanced                                                                     80                         1.00 (0.00, 7.00)    599                        2.00 (0.00, 8.00)    79                         1.00 (0.00, 4.00)    0.32                

  PBA-s Psychosis                                                              Early                      386                  0.00 (0.00, 0.00)          3878                 0.00 (0.00, 0.00)          625                  0.00 (0.00, 0.00)   0.17

  Moderate                                                                     137                        0.00 (0.00, 0.00)    1257                       0.00 (0.00, 0.00)    215                        0.00 (0.00, 0.00)    0.06                

  Advanced                                                                     69                         0.00 (0.00, 0.00)    547                        0.00 (0.00, 0.00)    77                         0.00 (0.00, 0.00)    0.22                

  PBA-s Apathy                                                                 Early                      387                  1.00 (0.00, 6.00)          3884                 0.00 (0.00, 4.00)          624                  0.00 (0.00, 4.00)   **\* \<0.01**

  Moderate                                                                     138                        3.00 (0.00, 8.00)    1258                       4.00 (0.00, 9.00)    215                        6.00 (0.00, 9.00)    0.10                

  Advanced                                                                     71                         8.00 (0.00, 12.00)   555                        8.00 (0.00, 12.00)   77                         8.00 (1.00, 12.00)   0.97                

  PBA-s Executive function                                                     Early                      386                  0.00 (0.00, 4.00)          3874                 0.00 (0.00, 4.00)          623                  0.00 (0.00, 4.00)   **\* \<0.01**

  Moderate                                                                     137                        4.00 (0.00, 9.00)    1256                       3.00 (0.00, 9.00)    215                        2.00 (0.00, 6.00)    0.16                

  Advanced                                                                     71                         6.00 (0.00, 12.00)   541                        6.00 (0.00, 10.00)   76                         4.00 (0.00, 9.00)    0.34                

  PBA-s Depressed mood frequency Present vs. Not Present                       Early                      389                  224 (57.58)                3889                 2064 (53.07)               625                  267 (42.72)         **\* \<0.01**

  Moderate                                                                     139                        60 (43.17)           1265                       623 (49.25)          215                        98 (45.58)           0.28                

  Advanced                                                                     82                         45 (54.88)           617                        323 (52.35)          81                         45 (55.56)           0.81                

  PBA-s Suicidal ideation frequency Present vs. Not Present                    Early                      389                  40 (10.28)                 3889                 363 (9.33)                 625                  39 (6.24)           **\* 0.03**

  Moderate                                                                     139                        13 (9.35)            1265                       110 (8.70)           215                        21 (9.77)            0.86                

  Advanced                                                                     82                         15 (18.29)           617                        100 (16.21)          81                         14 (17.28)           0.88                

  PBA-s Anxiety frequency Present vs. Not Present                              Early                      389                  235 (60.41)                3889                 2225 (57.21)               625                  316 (50.56)         **\* \<0.01**

  Moderate                                                                     139                        69 (49.64)           1265                       691 (54.62)          215                        125 (58.14)          0.29                

  Advanced                                                                     82                         48 (58.54)           617                        333 (53.97)          81                         36 (44.44)           0.17                

  PBA-s Irritability frequency Present vs. Not Present                         Early                      389                  228 (58.61)                3889                 2124 (54.62)               625                  303 (48.48)         **\* \<0.01**

  Moderate                                                                     139                        72 (51.80)           1265                       690 (54.55)          215                        106 (49.30)          0.33                

  Advanced                                                                     82                         49 (59.76)           617                        353 (57.21)          81                         46 (56.79)           0.90                

  PBA-s Angry or aggressive behavior frequency Present vs. Not Present         Early                      389                  129 (33.16)                3889                 1091 (28.05)               625                  135 (21.60)         **\* \<0.01**

  Moderate                                                                     139                        41 (29.50)           1265                       417 (32.96)          215                        49 (22.79)           **\* 0.01**         

  Advanced                                                                     82                         29 (35.37)           617                        238 (38.57)          81                         24 (29.63)           0.27                

  PBA-s Lack of initiative (apathy) frequency Present vs. Not Present          Early                      389                  209 (53.73)                3889                 1944 (49.99)               625                  264 (42.24)         **\* \<0.01**

  Moderate                                                                     139                        88 (63.31)           1265                       884 (69.88)          215                        147 (68.37)          0.27                

  Advanced                                                                     82                         63 (76.83)           617                        469 (76.01)          81                         62 (76.54)           0.98                

  PBA-s Perseverative thinking or behavior frequency Present vs. Not Present   Early                      389                  128 (32.90)                3889                 1493 (38.39)               625                  210 (33.60)         **\* 0.01**

  Moderate                                                                     139                        76 (54.68)           1265                       759 (60.00)          215                        119 (55.35)          0.25                

  Advanced                                                                     82                         53 (64.63)           617                        408 (66.13)          81                         50 (61.73)           0.72                

  PBA-s Obsessive-Compulsive Behaviors frequency Present vs. Not Present       Early                      389                  100 (25.71)                3889                 800 (20.57)                625                  96 (15.36)          **\* \<0.01**

  Moderate                                                                     139                        42 (30.22)           1265                       353 (27.91)          215                        49 (22.79)           0.22                

  Advanced                                                                     82                         33 (40.24)           617                        207 (33.55)          81                         20 (24.69)           0.11                

  PBA-s Delusions frequency Present vs. Not Present                            Early                      389                  26 (6.68)                  3889                 198 (5.09)                 625                  21 (3.36)           **\* 0.05**

  Moderate                                                                     139                        13 (9.35)            1265                       124 (9.80)           215                        12 (5.58)            0.14                

  Advanced                                                                     82                         24 (29.27)           617                        120 (19.45)          81                         10 (12.35)           **\* 0.02**         

  PBA-s Hallucinations frequency Present vs. Not Present                       Early                      389                  6 (1.54)                   3889                 47 (1.21)                  625                  7 (1.12)            0.82

  Moderate                                                                     139                        7 (5.04)             1265                       36 (2.85)            215                        1 (0.47)             **\* 0.02**         

  Advanced                                                                     82                         17 (20.73)           617                        105 (17.02)          81                         6 (7.41)             **\* 0.05**         

  PBA-s Disoriented Behavior frequency Present vs. Not Present                 Early                      389                  78 (20.05)                 3889                 666 (17.13)                625                  104 (16.64)         0.31

  Moderate                                                                     139                        54 (38.85)           1265                       534 (42.21)          215                        102 (47.44)          0.23                

  Advanced                                                                     82                         49 (59.76)           617                        436 (70.66)          81                         58 (71.60)           0.12                
  ---------------------------------------------------------------------------- -------------------------- -------------------- -------------------------- -------------------- -------------------------- -------------------- ------------------- ---------------

\* Significant at level p \< 0.05.

PBA-s = Problem Behaviours Assessment -- Short, UHDRS = Unified Huntington's Disease Rating Scale, HADS-SIS = Hospital Anxiety and Depression Scale -- Snaith Irritability Scale.

At moderate stages of disease, late onset participants were significantly more likely than young onset participants to have worse HADS-SIS depression (8.00 \[4.00--11.00\] vs. 5.00 \[3.00--8.00\], p \< 0.001) and HADS-SIS inward irritability (2.50 \[1.00--4.00\] vs. 1.00 \[0.00--3.00\], p = 0.006) (Table [3](#T3){ref-type="table"}, Appendix A). HADS-SIS depression and anxiety scores are normal 0-7, borderline 8--10, and abnormal 11--21 \[[@B20]\]. HADS-SIS inward irritability scores are normal \<4 and outward irritability scores are normal \<5 \[[@B21]\].

Behavioral symptom profiles also differed significantly between the typical onset group and the late onset group at early stages of disease. At early stages of disease, typical onset participants were significantly more likely than late onset participants to abuse drugs and alcohol, have worse anxiety, depression, irritability, apathy, executive function, suicidal ideation frequency, angry or aggressive behavior, lack of initiative, and obsessive-compulsive behaviors (Table [3](#T3){ref-type="table"}, Appendix A).

At moderate stages of HD, typical onset participants scored significantly worse compared to late onset participants on drug abuse (6.66% vs. 1.87%, p = 0.004) and PBA-s Angry or aggressive behavior frequency (32.96% vs. 22.79%, p = 0.003) (Table [3](#T3){ref-type="table"}, Appendix A).

Disease Progression
-------------------

With exclusions applied to remove variability in time of follow-up assessments, 1,467 manifest HD participants were included in the sensitivity analysis determining average change in TFC score. The average decline in mean TFC score from baseline to second visit (1.5 to 2.5 years) was significantly faster in the young onset participants (--1.75 points) compared to the typical (--1.23 points, p = 0.0105) or late onset (--0.97 points, p = 0.0017) participants. From baseline to third visit (2.5 to 3.5 years), the young onset participants again declined significantly faster (--2.27 points) when compared to the late onset group (--1.28 points, p = 0.0002), and the typical group declined faster than the late onset group (--1.81 points, p = 0.005) (Figure [A](#F1){ref-type="fig"}).

![**Average change in TFC score by age-of-onset groups.** Young age of onset group shows markedly increased rate of decline compared to typical and late onset groups. Δ = difference in mean TFC score, BL = baseline.](tohm-10-1-536-g1){#F1}

1,406 manifest HD participants were included in the sensitivity analysis determining average change in UHDRS Functional Assessment Independence Scale. Results reinforced the changes seen in TFC score: the average decline in mean Independence Scale score from baseline to second visit was significantly faster in the young onset participants (--3.53 points) compared to the typical (--2.35 points, p = 0.002) or late onset participants (--2.01 points, p = 0.001). From baseline to third visit, the young onset group again declined significantly faster (--4.62 points) compared to the typical (--3.52 points, p = 0.013) and late onset (--2.92 points, p = 0.001) groups (Figure [B](#F2){ref-type="fig"}).

![**Average change in UHDRS Functional Assessment Independence Scale.** Young age of onset shows markedly increased rate of decline compared to typical and late onset groups from baseline to second visit and third visit. Δ = difference in mean FA score, BL = baseline.](tohm-10-1-536-g2){#F2}

Discussion
==========

This analysis corroborates previous findings that symptom burden profile and HD progression differ significantly by age of onset \[[@B4]\]. Knowledge of the expected symptoms profile for different age of onset groups throughout disease progression will help to inform appropriate care of HD patients. Further, a strength of this study is that it clearly defines statistically significant phenotypic differences between the given age groups. Young adult onset (20--29 years) is a novel age group proposed by this study, and our analysis validates the separation of this cohort from the typical onset group based on distinct differences in symptom profile and most clearly in terms of rate of disease progression (Figure [A](#F1){ref-type="fig"} and [B](#F2){ref-type="fig"}). This study distinguishes young adult onset as a clinically unique phenotype, similar to the distinction of juvenile Huntington's disease, which is defined by features of increased behavioral symptoms and faster progressors in functional decline \[[@B10][@B12][@B22]\]. While we recognize these differences likely exist on a continuum rather than stop at our defined age of onset cutoff point, our study shows that younger skewing adult onset participants warrant special considerations in management of their HD.

Regarding behavioral symptoms, at early stages of disease, young onset participants were more likely than late onset participants to suffer from worse behavioral symptoms, including drug and alcohol abuse, anxiety, depression, irritability, aggression, apathy, lack of initiative, obsessive-compulsive behaviors, and delusions. At moderate stages of disease, this preponderance of behavioral symptom burden diminishes, and late onset participants were found to have more depression and inward irritability when compared to the young onset group. At advanced stages of disease, the young onset group was again found to have a greater prevalence of drug abuse, hallucinations, and delusions than the late onset group.

A similar trend was also found in early and moderate stages of disease when comparing the typical onset group to the late onset group. At early stages of disease, the typical onset participants were more likely than late onset participants to abuse drugs and alcohol, have anxiety, depression, irritability, apathy, decreased executive function, increased suicidal ideation, angry or aggressive behavior, lack of initiative, and obsessive-compulsive behaviors. At moderate stages of disease, typical onset participants were more likely than late onset participants to abuse drugs and have angry or aggressive behavior.

These findings support previous suggestions that HD patients with young age of onset have a greater behavioral symptom burden at early disease stage, while late age-of-onset patients have greater motor burden at early stages \[[@B4]\]. Additionally, these findings reinforce our clinical observations, in which younger onset patients are more psychiatrically affected than older onset patients with the same degree of functional impairment. This study builds upon those findings by showing that typical onset participants have a significantly greater burden of behavioral symptoms profiles when compared to late onset participants at both early and moderate stages of disease. Further, although it varies by disease state evaluated, HADS-SIS score has been shown to have a minimal clinically important difference of about 1.5; thus even the small intergroup differences described in this study can affect symptom presentation and management \[[@B23]\].

Additionally, our study makes the important distinction that after adjusting for TFC score, young and typical age of onset participants still had a greater burden of behavioral symptoms compared to the late onset group. Traditionally, expanded CAG allele repeats associated with more aggressive disease have been used to explain the increased burden of behavioral symptoms in people with younger age of onset \[[@B1]\]. However, differences in symptom profiles were observed between the age of onset groups when compared at the same stage of disease severity (Table [3](#T3){ref-type="table"}). These findings are corroborated by a previous study, which showed no correlation between CAG repeat length and psychiatric symptoms in HD \[[@B24]\]. Thus, other factors may explain the observed behavioral differences.

Social factors and anxiety about disease progression likely play into the behavioral differences observed. Young people in families with HD endure considerable anxiety and have a lack of support in relation to their HD risk \[[@B25]\]. This burden of anxiety and lack of social support could become magnified once HD manifests. Specifically, lack of social support is associated with decreased quality of life for patients with neurodegenerative diseases \[[@B26]\]. Additionally, given their young age of onset and the genetic nature of HD, these participants are more likely to be caretakers for living family members affected by HD, which has been shown to cause high rates of family dysfunction, psychological stress, and significantly affect quality of life \[[@B27][@B28][@B29]\]. Even when controlling for CAG repeat length, HD patients with a family history of HD have been shown to have earlier depression onset and are more likely to have behavioral manifestations as their initial major symptom compared to de novo HD patients \[[@B30]\]. Thus, the young age of onset group may have to deal with the emotional stress of their HD, which is potentially compounded by the emotional stress of caring for ailing HD family members \[[@B31]\].

Besides caring for affected relatives, young age of onset HD patients may also have to manage functional decline with the social expectations of young adult life, such as family planning and employment \[[@B31]\]. Notably, 78.89% of the young onset participants were unemployed, compared to 77.41% in typical onset and 91.40% in late onset (Table [1](#T1){ref-type="table"}). While the unemployment rate is not significantly higher in the young onset group, loss of employment at a younger age could be an exacerbating factor for functional decline in the young onset population. There is compelling evidence that the cognitive and functional decline due to HD could cause loss of employment and contribute to exacerbation of behavioral symptoms. A previous study utilizing Enroll-HD found that the functional declines associated with HD contributed to HD patients leaving the workforce earlier \[[@B32]\]. Leaving the labor force has been found to be associated with higher risk of poor physical and mental health in adults \[[@B33]\]. This increased risk for mental illness is likely exacerbated in the young onset group, given they have less opportunity to participate in the workforce compared to late onset participants.

With respect to motor symptoms, this analysis shows that at early disease stages, the late onset group had worse motor function compared to the young onset group. At advanced stages of disease, young onset participants tended to have worse motor function than their late onset counterparts. Therefore, this study indicates that the greater burden of motor symptoms in the late onset group does not persist into more severe disease. At early disease stages, participants with late onset HD potentially have more motor deficits due to natural loss of function from aging. At later stages, HD patients are likely all similarly affected by injury to striatal networks. Further studies are warranted to elucidate why the young onset group had worse motor function with more advanced HD.

Our study found no significant trends regarding differences in cognitive variables between age groups and across stages of disease. This is somewhat surprising, given that age is a risk factor for dementia and cognitive decline \[[@B34]\]. Cognitive decline may be difficult to predict given the number of factors that influence cognitive reserve, such as exercise levels, intelligence level, occupational status, and years of education \[[@B34][@B35][@B36]\]. However, the Enroll-HD study participants analyzed in our study were relatively matched in education level and employment status (Table [1](#T1){ref-type="table"}); therefore, we can expect all groups would have relatively equal levels of cognitive reserve.

The evidence relating cognitive decline in HD to age of onset prior to this study have been mixed. A previous study found cognitive status was better preserved in younger onset HD patients when compared to later onset patients \[[@B37]\]. Other studies suggested found that CAG repeats, which are correlated with earlier onset, were strongly associated with striatal atrophy and that subcortical atrophy, specifically atrophy of the head of the caudate nucleus, were positively associated with cognitive deficits \[[@B1][@B38][@B39]\]. More aggressive disease in the young onset group could potentially be equal to the cognitive deficits caused by aging in the late onset group, thus leading to our result of no significant intergroup differences in cognitive function.

Finally, young age of onset is predictive of a faster functional decline for adults with HD when compared to those with typical and late age of onset. This finding is consistent with the fact that younger age of onset is associated with expanded CAG repeats, which have been associated with faster and more widespread basal ganglia atrophy \[[@B1][@B40][@B41]\]. This result directly contradicts the highly cited 1995 study by Feigin et al. which reported that there was no correlation found between functional decline and age of onset in 129 manifest HD patients studied \[[@B5]\]. A 2003 study published by Mahant et al. had results more consistent with ours: in 1,026 patients, the rate of decline in UHDRS total motor score and Independence Scale was significantly faster with a younger age of onset \[[@B6]\]. However, their study included patients with juvenile onset HD and found no association with total functional capacity.

This study makes the important distinction that the association between faster functional decline and younger age of onset persists in the context of adult HD. Additionally, this study was able to show a novel correlation between younger age of onset and a global measure of functional capacity, TFC score. This study shows these robust associations in larger and more diverse HD population followed over the course of 3 years. These findings, paired with the finding that younger age of onset participants had a greater burden of behavioral symptoms, suggest that behavioral symptoms may contribute more significantly to functional decline in this younger population.

Our findings have important implications for the treatment and prognosis of HD. Particularly, patients with a young and typical age of onset should be screened for behavioral symptoms and directed towards resources which will help them more effectively manage these symptoms. This study can help family members and caretakers become more aware that behavioral issues are likely to manifest in patients with earlier HD onset. Given that motor symptoms are worse for young onset patients at later stages of disease, preventative and early interventions with modalities such as physical therapy can be implemented into their care plans \[[@B42]\]. Similar adaptations of our findings can be implemented to tailor treatments and interventions for typical and late onset HD patients.

Limitations
-----------

Since this study was cross-sectional and observational, this precludes us from making causative explanations between the variables studied and limits our conclusions to associations. Although we used rater determination of symptom onset, this estimation of age of onset could still be imprecise and amount to some discrepancy in the actual age of onset of manifest HD and the group assigned in this study. Study participants were categorized based on their TFC score at baseline and the motor, cognitive, and behavioral variables analyzed were determined from baseline visits. This cross-sectional design meant we could not account for interpersonal differences in the participant population. We are limited by the amount of follow-up data currently available in Enroll-HD. Sufficient TFC data points to analyze functional decline were only available up to visit 3, and these participants represented 20.88% of manifest HD patients in the Enroll-HD database. Insufficient powering also limited analyses at advanced stages of disease, since there were less than 1,000 participants at TFC Stages IV and V.

Future directions
-----------------

Future longitudinal analyses are necessary to expand on and elucidate the findings of this study. Particularly, a multifactorial cause for the greater burden of behavioral symptoms in younger onset HD patients should be investigated. As the Enroll-HD database continues to grow, future studies may be able to better examine the disease course and phenotype of HD, particularly in its advanced stages.

Conclusions
===========

Young age of onset is predictive of a faster functional decline for adults with HD when compared to those with typical and late age of onset. HD patients with a young age of onset have a greater burden of behavioral symptoms at early stages of disease, suggesting that behavioral symptoms may contribute more significantly to functional decline in this younger population. Motor deficits are comparatively worse for late onset participants at early stages of HD, and worse at advanced stages for young onset participants.
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